Healthcare-associated infections in long-term care facilities (HALT) in Frankfurt am Main, Germany, January to March 2011

Eurosurveillance

Volumn 17, Issue 35, 2012, Pages

  Heudorf, U ^a   Boehlcke, K ^a   Schade, M ^a  

^a Public Health Authorities   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIVIRUS AGENT; BETA LACTAM ANTIBIOTIC; CEPHALOSPORIN DERIVATIVE; COTRIMOXAZOLE; LINCOSAMIDE DERIVATIVE; MACROLIDE; NITROFURANTOIN; PENICILLIN DERIVATIVE; QUINOLONE DERIVATIVE; STREPTOGRAMIN DERIVATIVE; TETRACYCLINE DERIVATIVE;

ADULT; AGED; ARTICLE; CLINICAL FEATURE; DERMATOMYCOSIS; DRUG USE; EYE INFECTION; FEMALE; GASTROINTESTINAL INFECTION; GERMANY; HEALTHCARE ASSOCIATED INFECTION; HOSPITAL BED CAPACITY; HUMAN; INFECTION CONTROL; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; NURSING HOME; NURSING STAFF; PERIODONTITIS; PREVALENCE; QUESTIONNAIRE; RESIDENT; RESPIRATORY TRACT INFECTION; RISK FACTOR; SKIN INFECTION; URINARY TRACT INFECTION;

EID: 84866361318     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. European Commission. Public consultation on strategies for improving patient safety by prevention and control of healthcare-associated infections. Luxembourg: European Commission. [Accessed 26 Aug 2012]. Available from:http://ec.europa.eu/health/ph_threats/com/cons01_txt_en.pdf
2. Engelhart S, Lauer A, Simon A, Exner D, Heudorf U, Exner M. [Repeated prevalence investigations of nursing home-associated infections as a tool to assess the hygienic quality of care]. Bundesgesund¬heitsblatt Gesundheitsforsch Gesundheitsschutz. 2009;52(10):936-44. German.
3. Andersen BM, Rasch M. Hospital-acquired infections in Norwegian long-term-care institutions. A three-year survey of hospital-acquired infections and antibiotic treatment in nursing/residential homes, including 4500 residents in Oslo. J Hosp Infect. 2000;46(4):288-96.
4. Eriksen HM, Iversen BG, Aavitsland P. Prevalence of nosocomial infections and use of antibiotics in long-term care facilities in Norway, 2002 and 2003. J Hosp Infect. 2004;57(4):316-20.
5. Nicolle LE, Garibaldi RA. Infection control in long-term-care facilities. Infect Control Hosp Epidemiol. 1995 16(6):348-53.
6. Stone SP. Soil, seed and climate: developing a strategy for prevention and management of infections in UK nursing homes. J Hosp Infect. 1999;43 Suppl:S29-38.
7. Nicolle LE, Strausbaugh LJ, Garibaldi RA. Infections and antibiotic resistance in nursing homes. Clin Microbiol Rev. 1996;9(1):1-17.
8. Moro ML, Mongardi M, Marchi M, Taroni F. Prevalence of long-term care acquired infections in nursing and residential homes in the Emilia-Romagna Region. Infection. 2007;35(4):250-5.
9. Stevenson KB, Moore J, Colwell H, Sleeper B. Standardized infection surveillance in long-term care: interfacility comparisons from a regional cohort of facilities. Infect Control Hosp Epidemiol. 2005;26(3):231-8.
10. Mylotte JM. Analysis of infection control surveillance data in a long-term facility: use of threshold testing. Infect Control Hosp Epidemiol. 1996;17(2):101-7.
11. Heudorf U, Schulte D. [Surveillance of nosocomial infections in a long-term care facility. Incidence and risk factors]. Bundesgesundheitsblatt Gesundheitsforsch Gesundheitsschutz. 2009;52(7):732-744. German.
12. Engelhart ST, Hanses-Derendorf L, Exner M, Kramer MH. Prospective surveillance for health care-associated infections in German nursing home residents. J Hosp Infection. 2005;60(1):46-50.
13. Jackson MM, Fierer J, Barrett-Connor E, Fraser D, Klauber MR, Hatch R, et al: Intensive surveillance for infections in a three-year study of nursing home patients. Am J Epidemiol. 1992;135(6):685-96.
14. Makris AT, Morgan L, Gaber DJ, Richter A, Rubino JR. Effect of a comprehensive infection control program on the incidence of infections in long-term care facilities. Am J Infect Control. 2000;28(1):3-7.
15. Smith PW, Rusnak PG. Infection prevention and control in the long-term care facility. SHEA Long-Term-Care Committee and APIC Guidelines Committee. Infect Control Hosp Epidemiol. 1997;18(12):831-49.
16. Latour K, Jans B, the HALT management team. Healthcare associated infections in long-term care facilities. Results of the pilot point prevalence survey. November 2009. Deposit number D/2011/2505/8; IPH/Epi-report number: 2011-006. [Accessed 26 Aug 2012]. Available from: http://halt.wiv-isp.be/report/Reports/HALT-1/HALT%20Report%20Pilot%20Survey%20Nov%202009.pdf
17. European Centre for Disease Prevention and Control (ECDC). About HALT-2. Background. Stockholm: ECDC. [Accessed 26 Aug 2012]. Available from: http://halt.wiv-isp.be/about/page/background.aspx
18. European Centre for Disease Prevention and Control (ECDC). The HALT project. How to perform a successful HALT Point Prevalence Survey (PPS)? 2009-2010. Stockholm: ECDC. HALT_PPS2. [Accessed 26 Aug 2012]. Available from: http://halt.wiv-isp.be/manual/Study%20documents%20PPS2/Forms/AllItems.aspx
19. Health Protection Surveillance Centre (HPSC). European point prevalence survey on healthcare associated infections and antibiotic use in long-term care facilities. National report-Republic of Ireland. November 2010. Dublin: HPSC. [Accessed 26 Aug 2012]. Available from:http://www.hpsc.ie/hpsc/AZ/MicrobiologyAntimicrobialResistance/InfectionControlandHAI/Surveillance/HCAIinlongtermcarefacilities/HALTproject2010/Results/File,4723, en.pdf
20. Wischnewski N, Mielke M, Wendt C. [Healthcare-associated infections in long-term care facilities (HALT). German results of the European prevalence study HALT]. Bundesgesundheitsblatt Gesundheitsforsch Gesundheitsschutz. 2011;54(11):1147-52. German.
21. Health Protection Scotland (HPS). Healthcare associated infections in European long term care facilities (HALT). Prevalence study 2010 in Scotland. Glasgow: HPS; June 2011. [Accessed 26 Aug 2012] Available from:http://www.documents.hps.scot.nhs.uk/hai/sshaip/publications/halt/halt-prevalence-2010.pdf
22. Eilers R, Veldman-Ariesen MJ, Haenen A, van Benthem BH. Prevalence and determinants associated with healthcare-associated infections in long-term care facilities (HALT) in the Netherlands, May to June 2010. Euro Surveill. 2012;17(34):pii=20252. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20252
23. McGeer A, Campbell B, Emori TG, Hierholzer WJ, Jackson MM, Nicolle LE, et al. Definitions of infection for surveillance in long-term care facilities Am J Infect Control. 1991;19(1):1-7.
24. Statistische Ämter des Bundes und der Länder, editor. Demografischer Wandel in Deutschland. Auswirkungen auf Krankenhausbehandlungen und Pflegebedürftige im Bund und in den Ländern. [Demographic change in Germany. Impact on hospital therapies and requirements for nursing in the Federal Republic of Germany and the German Federal States]. Wiesbaden: Statistisches Bundesamt; 2010. German. Available from:http://www.statistikportal.de/statistik-portal/demografischer_wandel_heft2.pdf
25. Lode H, Stahlmann R, Skopnik H. Rationaler Einsatz oraler Antibiotika bei Erwachsenen und Schulkindern (Lebensalter ab 6 Jahre). Empfehlungen einer Expertenkommission der Paul-Ehrlich-Gesellschaft für Chemotherapie e. V. [Rational use of oral antibiotics in adults and school children (children above 6 years). Findings of an expert commission of the Paul Ehrlich Society for Chemotherapy]. Chemotherapie Journal. 2006;15:129-44. [Accessed 26 Aug 2012]. German. Available from: http://www.chemotherapie-journal.de/archiv/artikel/2006/05/148.html
26. Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF). Harnwegsinfektionen bei erwachsenen Patienten, unkomplizierte bakterielle ambulant erworbene: Epidemiologie, Diagnostik, Therapie und Management. [Urinary infections. Epidemiology, diagnosis, therapy and management of community acquired urinary infections in adults]. Register number 043-044. Classification. Düsseldorf: AWMF. [Accessed 26 Aug 2012]. German. Available from: http://www.awmf.org/leitlinien/detail/ll/043-044.html
27. Höffken G, Lorenz J, Kern W, Welte T, Bauer T, Dalhoff K, et al. [Guidelines for the epidemiology, diagnosis, antimicrobial therapy and management of community-acquired pneumonia and lower respiratory tract infections in adults]. Dtsch Med Wochenschr. 2010;135(8):359-65. German.
28. Crnich CJ, Drinka P. Medical device-associated infections in the long-term care setting. Infect Dis Clin N Am. 2012;26(1):143-64.
29. von Eiff C, Jansen B, Kohnen W, Becker K. Infections associated with medical devices: pathogenesis, management and prophylaxis. Drugs. 2005;65(2)179-214.